Skip Navigation

QJM 2005 98(5):380-381; doi:10.1093/qjmed/hci062
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Limdi, J.K.
Right arrow Articles by Crampton, J.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limdi, J.K.
Right arrow Articles by Crampton, J.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Correspondence

Haemochromatosis and non-hepatic malignancy

The first 10% of the full text of this article appears below.

Sir,

We thank Dr Das for his interest in our recent review.1 He highlights the high risk of non-hepatic malignancies in hereditary haemochromatosis (HH).2 While the increased prevalence of hepatocellular cancer in HH is not in debate, controversy does surround the rate of non-hepatic malignancy in HH.

Some studies that suggested a higher incidence . . . [Full Text of this Article]

J.K. Limdi and J.R. Crampton

Wythenshawe Hospital South Manchester University Hospital Manchester email: jklimdi@doctors.org.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?